Geographic Variation in Hospice Use Prior to Death
Overview
Authors
Affiliations
Objectives: To examine national variation in use of the Medicare hospice benefit by older individuals before their death, and to identify individual characteristics and local market factors associated with hospice use.
Design: Retrospective analysis of Medicare administrative data.
Setting: Hospice care.
Participants: Older Medicare enrollees who died in 1996.
Measurements: Rate of hospice use per 1,000 older Medicare beneficiary deaths.
Results: Overall, 155 of every 1,000 older Medicare beneficiaries who die use hospice before death. This rate is significantly higher among younger older persons (P < .001), non-blacks (P < .001), persons living in wealthier areas (P < .001), and persons in urban areas (P < .001). Areas with a higher proportion of non-cancer diagnoses among hospice users have higher rates of hospice use for both cancer and non-cancer reasons than areas with a majority of hospice users having cancer diagnoses (P < .001). Hospice use is higher in areas with fewer hospital beds per capita (P < .001), areas with lower in-hospital death rates (P < .001), and areas with higher HMO enrollment (P < .001). Rates of hospice use are also positively related to average reimbursements for health care (P < .001) and to physicians per capita (P < .001). In the largest metropolitan statistical areas (MSAs), rates of hospice use vary more than 11-fold from a low of 35.15 (Portland, ME) to a high of 397.2 per 1,000 deaths (Ft. Lauderdale, FL).
Conclusions: The wide variation in hospice use suggests that there is great potential to increase the number of users of the Medicare hospice benefit.
Hoang M, Kareholt I, Schon P, von Koch L, Xu H, Tan E J Alzheimers Dis. 2023; 96(2):789-800.
PMID: 37840486 PMC: 10657673. DOI: 10.3233/JAD-230388.
Missing Voices: Lessons Learned from Nonparticipating Caregivers in Palliative Care Research.
Umaretiya P, Ilowite M, Fisher L, Bakitas M, Currie E, Gilbertson-White S J Palliat Med. 2022; 25(3):455-460.
PMID: 34981972 PMC: 8968850. DOI: 10.1089/jpm.2021.0433.
Khaki A, Xu Y, Cheung W, Li L, Fedorenko C, Grivas P JCO Oncol Pract. 2020; 16(12):e1543-e1552.
PMID: 32804586 PMC: 7735039. DOI: 10.1200/OP.20.00217.
Developing Predictive Models to Determine Patients in End-of-Life Care in Administrative Datasets.
Swerdel J, Reps J, Fife D, Ryan P Drug Saf. 2020; 43(5):447-455.
PMID: 31939079 PMC: 7165142. DOI: 10.1007/s40264-020-00906-7.
Chukwusa E, Verne J, Polato G, Taylor R, Higginson I, Gao W Int J Health Geogr. 2019; 18(1):8.
PMID: 31060555 PMC: 6503436. DOI: 10.1186/s12942-019-0172-1.